News
StockStory.org on MSN4d
Bristol-Myers Squibb (NYSE:BMY) Reports Upbeat Q1, Full-Year Outlook Slightly Exceeds ExpectationsBiopharmaceutical company Bristol Myers Squibb (NYSE:BMY) reported in Q1 CY2025, but sales fell by 5.6% year on year to $11.2 ...
StockStory.org on MSN4d
Merck’s (NYSE:MRK) Q1 Sales Beat EstimatesGlobal pharmaceutical company Merck (NYSE:MRK) in Q1 CY2025, but sales fell by 1.6% year on year to $15.53 billion. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results